After 30 years of speculation about whether the three month shot makes women more likely to contract HIV, we finally have an answer.
The ECHO trial is out: Depo Provera doesn’t lead to HIV
These are unprecedented times, and the role of media to tell and record the story of South Africa as it develops is more important than ever. But it comes at a cost. Advertisers are cancelling campaigns, and our live events have come to an abrupt halt. Our income has been slashed.
The Mail & Guardian is a proud news publisher with roots stretching back 35 years. We’ve survived thanks to the support of our readers, we will need you to help us get through this.
To help us ensure another 35 future years of fiercely independent journalism, please subscribe.